Latest News about LTRN
Recent news which mentions LTRN
3 AI Stocks to Buy Under $10 in August 2023
August 01, 2023
From InvestorPlace
7 AI Penny Stocks that Could Hit $5 Soon
July 30, 2023
From InvestorPlace
From Benzinga
From InvestorPlace
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 27, 2023
From Benzinga
7 AI Penny Stocks That Could Skyrocket in 2023
February 21, 2023
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
October 28, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
October 27, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 12, 2022
From Benzinga
Treating Pediatric Cancer? How Lantern Pharma Hopes To Improve The Lives Of Pediatric Cancer Patients During Childhood Cancer Awareness Month
September 15, 2022
Tickers
LTRN
From Benzinga
Lantern Pharma Touts Encouraging Positive Efficacy For Pancreatic Cancer Candidate
September 14, 2022
Tickers
LTRN
From Benzinga
Lantern Pharma's New Phase 2 Clinical Trial –Harmonic™ — Approved for Launch by the FDA
July 19, 2022
Tickers
LTRN
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For March 10, 2022
March 10, 2022
From Benzinga
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
March 06, 2022
From Benzinga
Benzinga Announces This Week's All Access Guests
January 27, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 24, 2022
From Benzinga
Lantern Pharma's LP-184 Receives Rare Pediatric, Orphan Drug Tags For Rare Form Of Cancer
January 24, 2022
Tickers
LTRN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.